Publications

  1. Barsky SH, Karlin NJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol. 2006 Mar; 3(3):138-51.
    View PubMed
  2. Karlin NJ, Weintraub N, Chopra IJ. Current controversies in endocrinology: screening of asymptomatic elderly for subclinical hypothyroidism. J Am Med Dir Assoc. 2004 Sep-Oct; 5(5):333-6.
    View PubMed
  3. Dexter W, Karlin N. Bad air days; Minimizing the risks for active people. Your Patient & Fitness in Internal Medicine. 1996 Aug; 10(4):27-30.
  4. Karlin N, Dexter W. High altitude illness; Detection and treatment. Your Patient & Fitness in Internal Medicine. 1996 Feb; 10(1):18-22.
  5. Karlin N. Munchausen syndrome by proxy. Brattleboro Retreat Psychiatry Review. 1995 Dec; 4(1).
  6. Hai C, Karlin N. Time-dependent uncoupling between myosin phosphorylation and contractile forces induced by Ca+2 depletion in smooth muscle. Archives Biochem & Biophysics. 1993 Mar; 301(2):299-304.
  7. Karlin N. Fotunatus and Catullus. Brown Classical Journal. 1991 Jun(7).
  8. Barsky SH, Karlin NJ. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia. 2005 Jul; 10(3):249-60.
    View PubMed
  9. Thapaliya P, Karlin NJ. An update on inflammatory breast cancer. Oncology Reviews. 2009; 3(2):73-8.
    View PubMed
  10. So C, Karlin N, Miller J. Testicular cancer: An unlikely etiology for iron deficiency anemia. Proceedings of UCLA Healthcare. 2009; 13.
  11. Khan O, Tong WP, Karlin NJ. Metastatic lung adenocarcinoma in a 20-year-old patient. Curr Oncol. 2010 Feb; 17(1):56-8.
    View PubMed
  12. Wong NW, Wong WW, Karlin NJ, Gray RJ. Radiation recall secondary to adjuvant docetaxel after balloon-catheter based accelerated partial breast irradiation. Radiography. 2010; 16(3):253-5 Epub 2010 Apr 28.
    View PubMed
  13. Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol. 2011 Feb 20; 29(6):e127-30. Epub 2010 Nov 29.
    View PubMed
  14. Geyer HL, Karlin N. Extraskeletal myxoid chondrosarcoma of the heart and review of current literature. Curr Oncol. 2010 Oct; 17(5):58-62.
    View PubMed
  15. Geyer HL, Viney J, Karlin N. Metastatic carcinoid presenting as a breast lesion. Curr Oncol. 2010 Nov; 17(6):73-7.
    View PubMed
  16. Kapetanakis V, Karlin NJ, McCullough AE, Magtibay PM. Primary ovarian malignant lymphoma presenting as ovarian carcinomatosis: a case report and literature review. Eur J Gynaecol Oncol. 2010; 31(6):701-2.
    View PubMed
  17. Vucicevic D, Carey E, Karlin N. Trastuzumab induced hepatotoxicity: Case Report and Review of the Literature (in press). Breast Care. 2012.
  18. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011; 81(1):9-11. Epub 2011 Sep 02.
    View PubMed
  19. Paripati HR, Karlin NJ, Schild SE, Vora SA, Dueck AC, Ross HJ. Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis. Journal of Geriatric Oncology. 2012; 3(2):104-10.
  20. Geyer H, Karlin N, Palen B, Mesa R. Asian-variant intravascular lymphoma in the African race. Rare Tumors. 2012 Jan 2; 4(1):e10. Epub 2012 Mar 19.
    View PubMed
  21. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01.
    View PubMed
  22. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C., Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s.
    View PubMed
  23. Karlin NJ, Dueck AC, Cook CB. Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr Pract. 2012 Nov-Dec; 18(6):898-905.
    View PubMed
  24. Bible KC, Suman VJ, Menefee ME, Smallridge RC, Molina JR, Maples WJ, Karlin NJ, Traynor AM, Kumar P, Goh BC, Lim WT, Bossou AR, Isham CR, Webster KP, Kukla AK, Bieber C, Burton JK, Harris P, Erlichman C, Mayo Phase, Mayo Clinic. Malignances Disease Oriented Group. A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab. 2012 Sep; 97(9):3179-84. Epub 2012 Jul 06.
    View PubMed
  25. Sikuyayenga M, Karlin N. An unusual case of a hemolytic crisis associated with the initiation of an aromatase inhibitor in a patient with known history of paroxysmal nocturnal hemoglobinuria. Cancer and Clinical Oncology. 2013; 2(1).
  26. Vucicevic D, Carey EJ, Karlin NJ. Trastuzumab-induced hepatotoxicity: a case report. Breast Care (Basel). 2013 May; 8(2):146-8.
    View PubMed
  27. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, for the Endocrine Malignancies Disease Oriented Group Mayo Clinic Cancer Center and the Mayo Phase 2 Consortium. Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99(5):1687-93. Epub 2014 Feb 25.
    View PubMed
  28. Karlin NJ, Dueck AC, Nagi Reddy SK, Verona PM, Cook CB. Implications of breast cancer with diabetes mellitus on patient outcomes and care. Diabetes Management. 2014; 4(5):411-19.
  29. Jatoi A , Radecki Breitkopf C , Foster NR , Block MS , Grudem M , Wahner Hendrickson A , Carlson RE , Barrette B , Karlin N , Fields AP . A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients. Oncology 2015; 88 (4):208-13 Epub 2014 Dec 06
    View PubMed
  30. Karlin NJ, Cheng M-R, Castro JC, Cook CB. Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus. Diabetes Management.2015 Nov;5:(6):441-8.
  31. Sakata KK , Gotway MB , Smith ML , Parish JM , Agrwal N , Karlin NJ , Swanson KL . Pulmonary Epithelioid Hemangioendothelioma Diagnosed With Endobronchial Biopsies: A Case Report and Literature Review. J Bronchology Interv Pulmonol 2016 Apr; 23 (2):168-73
    View PubMed
  32. Padrnos L, Karlin NJ, Halfdanarson TR. Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012 Rare Tumors (accepted). 2016.2016;1:(1):1.
  33. Karlin NJ, Kosiorek HE, Castro JC, Cook CB. Risk of Hospitalization in Patients With Diabetes Mellitus Who Have Solid-Organ Malignancy Future Science OA (accepted). 2016.2016;